
Walmart stock tumbled on weak comp sales. Is the stock in trouble?
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Walmart stock tumbled on weak comp sales. Is the stock in trouble?

Burry thinks Nvidia’s moat may face a tougher test

Moby summary of Twin Disc, Incorporated's Q4 2026 earnings call

Moby summary of Hovnanian Enterprises, Inc.'s Q3 2026 earnings call

Moby summary of Advance Auto Parts, Inc.'s Q2 2026 earnings call

Federal debt just crossed a staggering new threshold while Treasury scrambles to prop up the bond market, and the intervention collapsed within 24 hours. Where Berkshire puts its money instead reveals something most retirees holding long bonds have not yet reckoned with.

One restaurant chain is trading at a sky-high valuation while another has shed double digits this year, and the market's verdict defies everything a shaky consumer economy would predict about which business wins.

Brent crude just broke $95 and the August inflation print has not yet landed, which means the window to position ahead of the next dividend cycle is closing fast. Three energy companies are already converting the spike into bigger shareholder checks, and the structural reasons why they can keep doing it through an $80 pullback are worth understanding before prices move again.

Nvidia plans to start shipping small volumes of an AI chip designed for Chinese customers by the end of the year, The Information reported on Thursday, citing two employees. The chip giant did not immediately respond to a Reuters request for comment. Reuters could not independently verify the report.

Moby summary of Futu Holdings Limited's Q2 2026 earnings call

Moby summary of ScanSource, Inc.'s Q4 2026 earnings call
Seaport Therapeutics just went public with a prodrug platform that has attracted board members from two of the biggest neuroscience acquisitions in recent history. The question is whether the same giants who funded those deals are already circling for a third.

Tariff refunds couldn’t cover for comparable sales missing at 2.6%, and Target’s report the day before proved the excuse wasn’t going to fly

A late-night tariff pause between the U.S. and Canada left nothing signed and everything at stake, but three stocks are already pricing in a deal that could still fall apart before the ink dries.

SK Hynix followed the same post-IPO crash pattern as SpaceX and Cerebras, but what happened to its fundamentals during that stumble sets it apart from every other stock in the trillion-dollar club.

Moderna's stock just surged in a way that transforms the company from a cash-burning vaccine maker into a serious acquirer, and four biotech targets already sit within striking range of its newly loaded war chest.

Amazon invested just $13 billion in Anthropic.

The 40-year veteran fund manager resets his Nvidia forecast for the rest of the year.
The next test is whether strength extends into 2027

Moby summary of Lowe's Companies, Inc.'s Q2 2027 earnings call

Moby summary of Marti Technologies, Inc.'s Q2 2026 earnings call

Moby summary of FLEX LNG Ltd.'s Q2 2026 earnings call

Moby summary of The Estée Lauder Companies Inc.'s Q4 2026 earnings call

Moby summary of Datavault AI Inc.'s Q2 2026 earnings call

Moby summary of Viking Holdings Ltd's Q2 2026 earnings call

Moby summary of Analog Devices, Inc.'s Q3 2026 earnings call

The smartest move is to simply do nothing.

Anthropic just posted numbers that made OpenAI's growth look slow, and now it wants a $2 trillion valuation at IPO. Whether that price tag reflects a genuine breakthrough or a dangerous case of AI fever is the question every investor needs to answer before the market opens.

These healthcare companies can actually benefit from inflation.

During Cook's tenure as CEO, Apple's share price surged 2,180% higher.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.